Related Experiment Video
Updated: Jul 4, 2026
08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
New antigenic targets in type 1 diabetes
Janet M Wenzlau1, John C Hutton, Howard W Davidson
1Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA.
Summary
Zinc transporter 8 (ZnT8) is implicated in both type 1 and type 2 diabetes. Its role in beta-cell function and autoimmunity is crucial for understanding disease pathogenesis and early detection.
Area of Science:
- Endocrinology
- Immunology
- Genetics
Background:
- The zinc transporter isoform 8 (SLC30A8) is a beta-cell specific protein.
- SLC30A8 is recognized as a major autoantigen in type 1 diabetes and a genetic marker for type 2 diabetes.
Purpose of the Study:
- To investigate the role of cell specificity and localization of ZnT8 in the pathogenesis of type 1 and type 2 diabetes.
- To examine the hypothesis that ZnT8's characteristics contribute to disease development.
Main Methods:
- Review of existing literature on SLC30A8 in diabetes.
- Analysis of the association between SLC30A8 polymorphism and disease phenotypes.
- Consideration of cellular immune responses and autoantibody detection.
Main Results:
- Both type 1 and type 2 diabetes involve islet dysfunction, potentially linked to stress and secretory pathway changes.
- A common polymorphism in SLC30A8 (aa 325) influences autoantibody specificity in type 1 diabetes and is associated with beta-cell mass and secretion in type 2 diabetes.
Conclusions:
- Functional studies of ZnT8 are essential for understanding its role in type 2 diabetes.
- Investigating the cellular immune response to ZnT8 is crucial for its role in type 1 diabetes.
- Measuring ZnT8 autoantibodies may aid in prediabetes detection.
More Related Videos
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.